Ablaze Pharma
Closed- Website
- ablazepharma.com
- Total Funding
- $75.0M
- Last Round
- $75.0M Series ANov 2021
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Public company, acquired by Bristol Myers Squibb
Summary
Ablaze Pharma is a Biotech company. It has raised $75.0M in total across 1 round, most recently a $75.0M Series A round in Nov 2021. Investors include Vivo Capital, Advantech Capital and Nan Fung Life Sciences.
Funding History
Nov 2021
Investors
Similar Companies
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
The nation's first company to integrate specialty pharmacies into hospitals and health systems, h...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/ablaze-pharma"><img src="https://indexed.vc/api/badge/company/ablaze-pharma" alt="Ablaze Pharma on Indexed.vc" width="260" height="76" /></a>